Principal Financial Group
AUPH icon

Principal Financial Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Principal Financial Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Buy
133,591
+10,412
+8% +$166K ﹤0.01% 1825
2026
Q1 		$1.83M Buy
123,179
+7,964
+7% +$116K ﹤0.01% 1846
2025
Q4 		$1.84M Buy
115,215
+34,475
+43% +$489K ﹤0.01% 1854
2025
Q3 		$892K Buy
80,740
+5,074
+7% +$55.4K ﹤0.01% 1945
2025
Q2 		$641K Buy
75,666
+65,510
+645% +$525K ﹤0.01% 1957
2025
Q1 		$81.7K Sell
10,156
-160
-2% -$1.3K ﹤0.01% 2108
2024
Q4 		$92.6K Sell
10,316
-1,325
-11% -$10.8K ﹤0.01% 2155
2024
Q3 		$85.3K Sell
11,641
-11,951
-51% -$74.1K ﹤0.01% 2158
2024
Q2 		$135K Sell
23,592
-11,677
-33% -$61.5K ﹤0.01% 2194
2024
Q1 		$177K Buy
35,269
+485
+1% +$3.29K ﹤0.01% 2194
2023
Q4 		$313K Buy
34,784
+542
+2% +$4.46K ﹤0.01% 2052
2023
Q3 		$266K Sell
34,242
-1,007
-3% -$9.85K ﹤0.01% 2092
2023
Q2 		$341K Sell
35,249
-3,243
-8% -$33.7K ﹤0.01% 2043
2023
Q1 		$422K Sell
38,492
-3,010
-7% -$26.5K ﹤0.01% 2010
2022
Q4 		$179K Buy
41,502
+21,976
+113% +$128K ﹤0.01% 2219
2022
Q3 		$147K Sell
19,526
-1,285
-6% -$11.1K ﹤0.01% 2263
2022
Q2 		$209K Buy
+20,811
New +$233K ﹤0.01% 2290

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Principal Financial Group's AUPH Position: Q2 2026 in Review

Principal Financial Group increased its Aurinia Pharmaceuticals (AUPH) stake by 8.5% in Q2 2026, buying an estimated $166K and bringing the position to 133,591 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

Principal Financial Group first reported a position in AUPH in Q2 2022 and has held it in 17 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Principal Financial Group held 133,591 shares of Aurinia Pharmaceuticals worth $2.27M as of Q2 2026.
  • Principal Financial Group bought 10,412 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $166K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1825 holding.
  • Principal Financial Group first reported a position in Aurinia Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.